近期论文

1）Guo-Wu Rao（饶国武）*, Geng-Jie Xu, Jian Wang, Xu-Liang Jiang, and Hai-Bo Li, Synthesis, Antitumor Evaluation and Docking Study of Novel 4- Anilinoquinazoline Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors,ChemMedChem, 2013, 8(6), 928-933. IF 3.046 (二区). SCI 150UM.
2）Guo-Wu Rao*, Yan-Mei Guo and Wei-Xiao Hu, Synthesis, Structure Analysis, and Antitumor Evaluation of 3,6-Dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide Derivatives, ChemMedChem, 2012, 7(6), 973-976. IF 3.046(二区). SCI 947OI.
3）Guo-Wu Rao*, Cui Wang, Jian Wang, Zhen-Guo Zhao, Wei-Xiao Hu,Synthesis, structure analysis, antitumor evaluation and 3D-QSAR studies of 3,6- disubstituted-dihydro-1,2,4,5-tetrazine derivatives, Bioorg. Med. Chem. Lett., 2013, 23(23), 6474-6480. IF 2.331 (二区). SCI 244GC.
4）Guo-Wu Rao*, Cheng-Hai Hu, Jia-Bin Ni, Jian Wang, Cui Wang, Bing-Lan Wang, 3D-QSAR study using CoMFA and CoMSIA methods for a series of histone H3 phosphorylation inhibitors, Med. Chem. Res., 2014, 23(6), 3244-3254. SCI AE7NI.
5）饶国武，郭燕梅，陆晓晶，3,6-二甲基-1,2,4,5-四嗪-1,4-二甲酰胺类衍生物及制备和应用，2014.12，中国，ZL201110427026.0.
6）饶国武，郭燕梅，倪嘉斌，N1,N4-二正丁基-3,6-二甲基-1,2,4,5-四嗪-1,4-二甲酰胺及制备和应用，2014.06，中国，ZL201110428106.8.
7）饶国武，李琪，赵振国，N1,N4-二取代苯基-3,6-二甲基-1,2,4,5-四嗪-1,4-二甲酰胺的制备方法，2014.04，中国，ZL201110427616.3.